Cigna increases share repurchase authorization by $10B to $11.3B; plans $5B buyback by H1 2024

Cigna Group

Board approved $10B increase to share repurchase authorization; total authority now $11.3B.
Company intends to repurchase at least $5B of common stock by end of first half of 2024.
Portion of repurchase to be executed via accelerated share repurchase (ASR) program in Q1 2024.
Management believes shares are significantly undervalued; reaffirms FY2023 adjusted EPS outlook of at least $24.75.
Targets FY2024 consolidated adjusted EPS of at least $28.00; long-term adjusted EPS growth target of 10-13%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.